Your session is about to expire
← Back to Search
Educational Messages for Cardiovascular Disease (CONNECT Trial)
N/A
Recruiting
Led By Cheryl R Dennison Himmelfarb, PhD, RN, ANP
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant is 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6-months, and 12-months
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to increase the participation of underrepresented communities, such as women, Black adults, and Latino adults, in cardiovascular research. The CONNECT program provides tailored education on cardiovascular health and research participation,
Who is the study for?
The CONNECT trial is for US residents aged 18 or older who can read English or Spanish, self-identify with cardiovascular disease or risk factors like Type 2 Diabetes, obesity, high blood pressure, stroke, and high cholesterol. They must own a mobile phone and be open to receiving text messages.
What is being tested?
CONNECT aims to boost participation in cardiovascular research among underrepresented groups by providing tailored educational messages about heart health and study involvement via text. It connects participants to relevant studies and shares findings over a year.
What are the potential side effects?
Since this trial focuses on education through texts rather than medical interventions, there are no direct side effects related to drugs or treatments. However, participants may experience an increase in awareness and willingness to engage in clinical trials.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6-months, and 12-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6-months, and 12-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Participant accrual by priority population
Participant accrual by recruitment method
Secondary study objectives
Clinical trials awareness and knowledge will be assessed using items adapted from the Health Information National Trends Survey (HINTS)
Participant accrual in partnering cardiovascular research studies
Trust in Biomedical Research using the Perceptions of Research Trustworthiness Scale (PoRT)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Educational Text-Messages and Connection to Cardiovascular Research OpportunitiesExperimental Treatment1 Intervention
All participants who enroll in CONNECT, regardless of method of contact, will receive educational text messages and connection to cardiovascular research opportunities.
Group II: EHR-Informed Recruitment Sub-Study #1, Arm #2: Contact Method, EmailActive Control1 Intervention
Potential participants will be identified using an EHR query and will be randomized to receive a recruitment message via email. This message will invite the participant to join CONNECT.
Group III: EHR-Informed Recruitment Sub-Study #1, Arm #3: Contact Method, Postal MailActive Control1 Intervention
Potential participants will be identified using an EHR query and will be randomized to receive a recruitment message via postal mail. This message will invite the participant to join CONNECT.
Group IV: EHR-Informed Recruitment Sub-Study #1, Arm #1: Contact Method, Patient Portal MessageActive Control1 Intervention
Potential participants will be identified using an EHR query and will be randomized to receive a recruitment message via the patient portal message. This message will invite the participant to join CONNECT.
Find a Location
Who is running the clinical trial?
American Heart AssociationOTHER
346 Previous Clinical Trials
4,970,177 Total Patients Enrolled
Morgan State UniversityOTHER
6 Previous Clinical Trials
4,582 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,335 Previous Clinical Trials
14,874,713 Total Patients Enrolled
Cheryl R Dennison Himmelfarb, PhD, RN, ANPPrincipal InvestigatorJohns Hopkins School of Nursing
Hailey N Miller, PhD, RNPrincipal InvestigatorJohns Hopkins School of Nursing